VolitionRX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VolitionRX and other ETFs, options, and stocks.About VNRX
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids.
CEOCameron John Reynolds
CEOCameron John Reynolds
Employees85
Employees85
HeadquartersHenderson, Nevada
HeadquartersHenderson, Nevada
Founded1998
Founded1998
Employees85
Employees85
VNRX Key Statistics
Market cap36.20M
Market cap36.20M
Price-Earnings ratio-1.29
Price-Earnings ratio-1.29
Dividend yield—
Dividend yield—
Average volume2.47M
Average volume2.47M
High today$0.296
High today$0.296
Low today$0.27
Low today$0.27
Open price$0.2863
Open price$0.2863
Volume734.41K
Volume734.41K
52 Week high$0.94
52 Week high$0.94
52 Week low$0.22
52 Week low$0.22
Stock Snapshot
With a market cap of 36.2M, VolitionRX(VNRX) trades at $0.29. The stock has a price-to-earnings ratio of -1.29.
On 2026-01-19, VolitionRX(VNRX) stock traded between a low of $0.27 and a high of $0.30. Shares are currently priced at $0.29, which is +8.8% above the low and -0.7% below the high.
VolitionRX(VNRX) shares are trading with a volume of 734.41K, against a daily average of 2.47M.
In the last year, VolitionRX(VNRX) shares hit a 52-week high of $0.94 and a 52-week low of $0.22.
In the last year, VolitionRX(VNRX) shares hit a 52-week high of $0.94 and a 52-week low of $0.22.
People also own
Based on the portfolios of people who own VNRX. This list is generated using Robinhood data, and it’s not a recommendation.